期刊文献+

FTY720对体外混合培养淋巴细胞增殖和凋亡的影响 被引量:6

Effect of FTY720 on lymphocytes proliferation and apoptosis of in vitro mixed lymphocytes reaction
在线阅读 下载PDF
导出
摘要 目的观察FTY720对体外混合培养小鼠脾脏淋巴细胞的增殖、分化和凋亡的影响。方法将C57BL/6J小鼠与BALB/c小鼠的脾脏淋巴细胞体外混合培养5 d,培养液中加入不同浓度的FTY720。分别运用MTT法和流式细胞仪检测在不同浓度FTY720作用下,混合培养淋巴细胞的增殖状况、细胞表型和凋亡率。结果当FTY720为400 ng/mL时,体外混合培养淋巴细胞的增殖即受到明显抑制,抑制率为47.6%(P<0.05);当FTY720为3 200 ng/mL时,其抑制率达到为51.6%,呈剂量依赖性。FTY720为1 600 ng/mL时,混合培养淋巴细胞中的CD4+CD25+T细胞比例显著增加(P<0.05)。FTY720在200 ng/mL时,混合培养淋巴细胞的细胞凋亡率即显著增加(P<0.05)。结论在小鼠混合淋巴细胞培养体系中加入高浓度的FTY720,能显著抑制淋巴细胞增殖能力,增加调节性细胞的比例并促进细胞凋亡。 Objective To investigate the effect of FTY720 on lymphocytes proliferation, differentiation and apoptosis of in vitro mixed lymphocytes reaction (MLR). Methods Different concentrations of FTY720 were added to the primary MLR containing the splenocytes from BALB/c and C57BL/6J mice. The proliferative status, cell phenotype and apoptosis of the lymphocytes of MLR were measured by MTT assay and flow cytometry. Results FTY720 at concentration of 400 ng/mL could significantly suppress lymphocytes proliferation(P 〈0.05) with the inhibition rate of 47.6% , and that was 51.6% at concentration of 3 200 ng/mL, exhibiting a dose-dependent manner. At concentration of 1 600 ng/mL, the percentage of CD4 ^+ CD25 ^+ T cell in the MLR increased significantly ( P 〈 0.05). The percentage of apoptosis also rose significantly in the presence of FTY720 at concentration of 200 ng/mL ( P 〈 0.05 ). Conclusion FTY720 at high concentration significantly suppresses the lymphocytes proliferation in MLR, increases the percentage of regulatory T lymphocytes, and facilitates lymphocytes apoptosis.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第4期380-383,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30571767)~~
关键词 FTY720 增殖 调节性T细胞 凋亡 混合淋巴细胞培养 FTY720 proliferation regulatory T cell apoptosis mixed lymphocyte reaction
作者简介 施国海(1977-),男,黑龙江哈尔滨人,博士生;电子信箱:guohai8hi@126.com. 通讯作者:周佩军,电子信箱:peijunzhou@yahoo.com。
  • 相关文献

参考文献15

  • 1Chiba K,Hoshino Y,Suzuki C,et al.FTY720,a novel immunosuppressant possessing unique mechanisms.Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats[ J ].Transplant Proc,1996,28 (2):1056-1062.
  • 2Furukawa H,Suzuki T,Jin MB,et al.Prolongation of canine liver allograft survival by a novel immunosuppressant,FTY720:effect of monotherapy and combined treatment with conventional drugs[ J ].Transplantation,2000,69 (2):235-240.
  • 3Fujishiro J,Kudou S,Iwai S,et al.Use of sphingosine-l-phosphate 1 receptor agonist,KRP-203,in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation[J].Transplantation,2006,82 (6):804-812.
  • 4Sakagawa T,Kiyochi H,Honda K,et al.Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation[ J ].Transpl Immunol,2004,13 (3):161-168.
  • 5Skerjanec A,Tedesco H,Neumayer HH,et al.FTY720,a novel immunomodulator in de novo kidney transplant patients:pharmacokinetics and exposure-response relationship[J].J Clin Pharmacol,2005,45 (11):1268-1278.
  • 6Tedesco-Silva H,Mourad G,Kahan BD,et al.FTY720,a novel immunomodulator:efficacy and safety results from the first phase 2A study in de novo renal transplantation[J].Transplantation,2004,77(12):1826-1833.
  • 7Pinschewer DD,Ochsenbein AF,Odermatt B,et al.FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction,expansion,and memory[ J ].Immunol,2000,164 (11):5761 -5769.
  • 8Yopp AC,Ledgerwood LG,Ochando JC,et al.Sphingosine 1-phosphate receptor modulators:a new class of immunosuppressants[ J ].Clin Transplant,2006,20 (6):788-795.
  • 9Isoyama N,Takai K,Tsuchida M,et al.Evidence that FTY720 induces rat thymocyte apoptosis[ J ].Transpl Immunol,2006,15 (4):265-271.
  • 10Xie JH,Nomura N,Koprak SL,et al.Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4 + T cells[J].J Immunol,2003,170(7):3662 -3670.

同被引文献61

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部